dc.contributor.author | Rezazadeh, M | |
dc.contributor.author | Khorrami, A | |
dc.contributor.author | Yeghaneh, T | |
dc.contributor.author | Talebi, M | |
dc.contributor.author | Kiani, SJ | |
dc.contributor.author | Heshmati, Y | |
dc.contributor.author | Gharesouran, J | |
dc.date.accessioned | 2018-08-26T08:56:11Z | |
dc.date.available | 2018-08-26T08:56:11Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54407 | |
dc.description.abstract | Alzheimer’s disease is considered a progressive brain disease in the older population. Late-onset Alzheimer’s disease (LOAD) as a multifactorial dementia has a polygenic inheritance. Age, environment, and lifestyle along with a growing number of genetic factors have been reported as risk factors for LOAD. Our aim was to present results of LOAD association studies that have been done in northwestern Iran, and we also explored possible interactions with apolipoprotein E (APOE) status. We re-evaluated the association of these markers in dominant, recessive, and additive models. In all, 160 LOAD and 163 healthy control subjects of Azeri Turkish ethnicity were studied. The Chi-square test with Yates’ correction and Fisher’s exact test were used for statistical analysis. A Bonferroni-corrected p value, based on the number of statistical tests, was considered significant. Our results confirmed that chemokine receptor type 2 (CCR2), estrogen receptor 1 (ESR1), toll-like receptor 2 (TLR2), tumor necrosis factor alpha (TNF?), APOE, bridging integrator 1 (BIN1), and phosphatidylinositol-binding clathrin assembly protein (PICALM) are LOAD susceptibility loci in Azeri Turk ancestry populations. Among them, variants of CCR2, ESR1, TNF?, and APOE revealed associations in three different genetic models. After adjusting for APOE, the association (both allelic and genotypic) with CCR2, BIN1, and ESR? (PvuII) was evident only among subjects without the APOE ?4, whereas the association with CCR5, without Bonferroni correction, was significant only among subjects carrying the APOE ?4 allele. This result is an evidence of a synergistic and antagonistic effect of APOE on variant associations with LOAD. آ© 2015, Springer Science+Business Media New York. | |
dc.language.iso | English | |
dc.relation.ispartof | NeuroMolecular Medicine | |
dc.subject | adenine | |
dc.subject | apolipoprotein E | |
dc.subject | chemokine receptor CCR2 | |
dc.subject | chemokine receptor CCR5 | |
dc.subject | cytosine | |
dc.subject | estrogen receptor alpha | |
dc.subject | guanine | |
dc.subject | thymine | |
dc.subject | toll like receptor 2 | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | ApoE protein, human | |
dc.subject | apolipoprotein E | |
dc.subject | apolipoprotein E4 | |
dc.subject | BIN1 protein, human | |
dc.subject | CCR2 protein, human | |
dc.subject | clathrin assembly protein | |
dc.subject | estrogen receptor alpha, human | |
dc.subject | nuclear protein | |
dc.subject | PICALM protein, human | |
dc.subject | signal transducing adaptor protein | |
dc.subject | TLR2 protein, human | |
dc.subject | tumor necrosis factor | |
dc.subject | tumor suppressor protein | |
dc.subject | aged | |
dc.subject | allele | |
dc.subject | Alzheimer disease | |
dc.subject | APOE gene | |
dc.subject | Article | |
dc.subject | Azeri (people) | |
dc.subject | BIN1 gene | |
dc.subject | CCR2 gene | |
dc.subject | CCR5 gene | |
dc.subject | controlled study | |
dc.subject | ESR alpha gene | |
dc.subject | ESR1 gene | |
dc.subject | ethnicity | |
dc.subject | female | |
dc.subject | gene | |
dc.subject | gene locus | |
dc.subject | genetic association | |
dc.subject | genetic susceptibility | |
dc.subject | genetic variability | |
dc.subject | genotype | |
dc.subject | human | |
dc.subject | Iran | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | PICALM gene | |
dc.subject | priority journal | |
dc.subject | single nucleotide polymorphism | |
dc.subject | TLR2 gene | |
dc.subject | TNF alpha gene | |
dc.subject | Turk (people) | |
dc.subject | Alzheimer disease | |
dc.subject | biological model | |
dc.subject | ethnic group | |
dc.subject | gene frequency | |
dc.subject | genetic predisposition | |
dc.subject | genetics | |
dc.subject | late onset disorder | |
dc.subject | multifactorial inheritance | |
dc.subject | single nucleotide polymorphism | |
dc.subject | very elderly | |
dc.subject | Adaptor Proteins, Signal Transducing | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Alzheimer Disease | |
dc.subject | Apolipoprotein E4 | |
dc.subject | Apolipoproteins E | |
dc.subject | Estrogen Receptor alpha | |
dc.subject | Ethnic Groups | |
dc.subject | Female | |
dc.subject | Gene Frequency | |
dc.subject | Genetic Predisposition to Disease | |
dc.subject | Genotype | |
dc.subject | Humans | |
dc.subject | Iran | |
dc.subject | Late Onset Disorders | |
dc.subject | Male | |
dc.subject | Models, Genetic | |
dc.subject | Monomeric Clathrin Assembly Proteins | |
dc.subject | Multifactorial Inheritance | |
dc.subject | Nuclear Proteins | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Receptors, CCR2 | |
dc.subject | Toll-Like Receptor 2 | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.subject | Tumor Suppressor Proteins | |
dc.title | Genetic Factors Affecting Late-Onset Alzheimer’s Disease Susceptibility | |
dc.type | Letter | |
dc.citation.volume | 18 | |
dc.citation.issue | 1 | |
dc.citation.spage | 37 | |
dc.citation.epage | 49 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1007/s12017-015-8376-4 | |